The Scope of Our Partnerships
ACCRU has developed relationships with partners in pharmaceutical companies that strengthen their position in the market. Relationships with industry funding sponsors include but are not limited to Bristol Myers Squibb, Celgene, Genentech, Seattle Genetics, Exact Science, Incyte, Five Prime, Janssen and Bayer.
In addition, we have relationships in place with international research networks such as International Cholangio-carcinoma Research Network (ICRN) and the Austria/Asian GI Trial Group (AGITG). There is a continually growing demand for the ability to conduct multi-site clinical trials with these groups. Our partners have enabled our members to open more than 65 phase II and III studies across many types of cancer.